SCN2A takes center stage again as an autism gene

SCN2A codes for the alpha-2 subunit of the voltage-gated sodium channel and its mutations are implicated in Benign Familial Neonatal-Infantile Seizures (BFNIS). As BFNIS are rare, SCN2A has served as a model for age-related epilepsies rather than an important gene in clinical practice.  SCN2A has pretty much shaped the concept of dysfunctions of the axon initial segment (AIS) as a core pathology of benign infantile epilepsies in the first year of life. Some studies suggest an interesting mechanism for the striking age-related pattern seen in BFNIS.

Now SCN2A appears in a novel context. Three new studies published in Nature last week used whole-exome sequencing to identify genes with de novo mutations implicated in autism[1,2,3]. Despite over 2000 patients sequenced only few genes were discovered and SCN2A stood out due to independent observations in a Yale led study by Sanders et al, independently confirming earlier hints implicating it in autism spectrum disorders.

Model of SCN2A

Model of about half of the ion channel SCN2A from Modbase based on a bacterial ion channel. Rendered by PyMol.

As of now it is unclear how mutations in SCN2A result in autism but it might be worth noting that the critical period for seizures in BFNIS overlaps with the time period in which neurodevelopmental dysregulations in autism are expected – the first year of life.

Epilepsy research is moving past ion channels to genes previously implicated SCN2A in autism (neurexins, neuroligins, CNTNAP2) and autism research is rediscovering ion channels (SCN1A, em>SCN2A). Time to recycle the equipment for electrophysiology of ion channels.

12 thoughts on “SCN2A takes center stage again as an autism gene

  1. Pingback: Exome sequencing for neurological syndromes | EuroEPINOMICS

  2. Pingback: Exome sequencing in autism – the big picture and implications for epilepsy genetics | EuroEPINOMICS

  3. Pingback: Next Generation Sequencing as a diagnostic tool in the epilepsy clinic | EuroEPINOMICS

  4. Pingback: Be literate when the exome goes clinical | EuroEPINOMICS

  5. Pingback: One fish, two fish, red fish, blue fish – KCTD13 and neurogenetic studies in zebrafish | EuroEPINOMICS

  6. Pingback: Exome sequencing in epileptic encephalopathies – the powers that be | Beyond the Ion Channel

  7. Pingback: Less is more – gene identification in epileptic encephalopathies through targeted resequencing | Beyond the Ion Channel

  8. Pingback: Epileptic encephalopathies: de novo mutations take center stage | Beyond the Ion Channel

  9. Pingback: 2013 in review: top three lists and the gene finding of the year | Beyond the Ion Channel

  10. Pingback: Story of a genetic shape-shifter: SCN2A in benign seizures, autism and epileptic encephalopathy | Beyond the Ion Channel

  11. Pingback: Surrendering to genomic noise – de novo mutations in schizophrenia | Beyond the Ion Channel

  12. Pingback: The Channelopathist has left the building – here are our top ten posts of the last two years | Beyond the Ion Channel

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s